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Abstract
Many hundreds of botanicals are used in complementary and alternative medicine for therapeutic use as antimicrobials and
immune stimulators. While there exists many centuries of anecdotal evidence and few clinical studies on the activity and
efficacy of these botanicals, limited scientific evidence exists on the ability of these botanicals to modulate the immune and
inflammatory responses. Using botanogenomics (or herbogenomics), this study provides novel insight into inflammatory
genes which are induced in peripheral blood mononuclear cells following treatment with immunomodulatory botanical
extracts. These results may suggest putative genes involved in the physiological responses thought to occur following
administration of these botanical extracts. Using extracts from immunostimulatory herbs (Astragalus membranaceus,
Sambucus cerulea, Andrographis paniculata) and an immunosuppressive herb (Urtica dioica), the data presented supports
previous cytokine studies on these herbs as well as identifying additional genes which may be involved in immune cell
activation and migration and various inflammatory responses, including wound healing, angiogenesis, and blood pressure
modulation. Additionally, we report the presence of lipopolysaccharide in medicinally prepared extracts of these herbs
which is theorized to be a natural and active component of the immunostimulatory herbal extracts. The data presented
provides a more extensive picture on how these herbs may be mediating their biological effects on the immune and
inflammatory responses.
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Introduction
Many complementary and alternative medicine (CAM) ap-
proaches and interventions are thought to exert activities by
enhancing immune function. Botanical supplements are used
worldwide with the expectation of boosting the immune response
and reducing pathogen-associated symptoms [1]. For many
individuals, especially those living in third world nations, herbal
medicines are the only therapeutic resources available. In 1985,
the World Health Organization estimated that perhaps 80% of the
world population relied on herbs for primary health care needs
[2,3,4,5]. This widespread use of herbal medicines is not restricted
to developing countries, as it has been estimated that 12-31% of
patients in European countries utilize herbal medicines [2,3,4,5,6].
In the United States, nearly one out of every five Americans are
currently using some form of CAM [3]. The Journal of the American
Medical Association reported that between 1990 and 1997 the
prevalence of herbal remedy use increased 380% in the United
States [7]. Many animal studies and limited clinical studies have
demonstrated the efficacy of botanical remedies, such as Astragalus
membranaceus, related to immunopotentiating effects [8,9,10,11,12,
13,14,15,16,17,18,19,20,21]. Even with the widespread use and
acceptance, a complete understanding of the biochemistry and
mechanisms of action regarding herbal remedies has remained
largely unknown [21,22].
The actual medicinal relationship between plants and humans is
historically far-reaching. Ancient civilizations, as early as 2,800
B.C., have utilized herbal methodologies that are only now being
recognized by Western science [23]. Throughout the world, but
especially in Europe and Asia, a tremendous change in the use and
appreciation of herbal medicine has taken place. In Europe,
estimates show that over $2 billion are spent on herbal products
each year, and in Germany, at least 10% of the pharmaceutical
market is herbal-based medicine [2,4]. Herbal products represent
a major economic force in the United States as well, with an
estimated annual sales figure of $3.3 billion in 1998 [3]. The
increased use of complementary and alternative medicine is slowly
gaining support through increased studies by scientific researchers.
Traditional herbal medicine utilizes many botanicals thought to
strengthen the body’s resistance to illness through effects on the
immune system. Animal and clinical studies suggest that many
botanical extracts provide anticancer, pro-inflammatory, and anti-
infective activities [8,9,10,11,12,13,14,15,16,17,18,19,20,21].
Most herbs for the immune system are believed to act as general
immune system stimulators and are thought to alter immune
function through the dynamic regulation of cytokine expression
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North America. Though still mired in controversy, this herb
apparently exerts its antiviral activity primarily through stimula-
tion of the immune system [1,24,25]. Likewise, Astragalus spp. is
one of the primary herbs in Chinese medicine used in Europe and
Asia for antimicrobial activity [26,27,28]. Research suggests that
Astragalus spp. extracts may have some direct antibacterial activity
against both gram positive and negative bacteria while in vivo
studies suggest positive effects on patients and animals infected
with HSV, HIV, HBV or with viral myocarditis [8,27,29,30]. The
antiviral activity of Astragalus is thought to be mainly due to
modulatory effects on the immune system, specifically through the
induction of proinflammatory cytokines [21,25,31]. Though the
effect on cytokine expression by many botanicals has been
investigated, the number of cytokines measured has been limited.
The most frequently studied cytokines are IL1, IL2, IL4, IL6, TNF
and IFNgamma [21]. These cytokines are important pro-
inflammatory mediators and regulators of the immune response,
but provide a limited view of specific immunological activities.
Botanogenomics (also referred to as herbogenomics) is defined
as the analysis of the biological effect of a particular botanical
medicine through profiling of the affected genomic or proteomic
alterations [20]. This methodology can provide a novel mecha-
nistic understanding of the efficacy of a particular herbal
preparation. The goal of this study was to identify and to provide
additional insight into inflammatory genes induced in PBMCs
following treatment with immunomodulatory herbal extracts. This
data may provide a better understanding of how these herbs may
be inducing the physiological responses observed in individuals
following administration of various immunostimulatory herbal
products. Though many studies focus on identifying the key active
constituents present in a botanical extract, for this study the goal
was to measure changes in genetic expression in cells treated with
total herbal extracts which are commonly prescribed to individ-
uals. Using microarray analysis, novel genes which may be
involved in the immunostimulatory responses as well as other
known biological effects of these herbs were identified. This
provides a more complete understanding of the potential
mechanism of action, effectiveness, and global genetic effect of
these total botanical extracts on cells.
Materials and Methods
Botanical extract preparation
The following herbs were used in this study: Astragalus
membranaceus, Sambucus cerulea, Andrographis paniculata,
Echinacea angustifolia, Urtica dioica and Tylophora asmatica.
Fresh wild-crafted 6–8 inch leafy tops of Urtica dioica were
harvested from Western Washington, fresh Sambucus cerulea
flowers were harvested from north central Washington State, and
fresh Echinacea angustifolia roots were harvested from central
Kansas. All fresh plants were shipped overnight express to the
manufacturing facility for immediate validation and processing.
Fresh plant material was validated using taxonomic keys. Dried
Astragalus membranaceus root slices and dried Andrographis
paniculata herb were purchased from Mayway Corporation
(Oakland, CA), and dried Tylophora indica whole leaf was
purchased from Hillgreen Company (Bangalore, India). Dried
plant material was validated using herbal pharmacopoeia
monographs. Fresh plants were mixed with distilled water/190
proof ethanol/glycerol at a ratio of 1:2.5 (Urtica and Sambucus)o r
1:3 (Echinacea) [weight of botanical to volume of liquid], ground
gently in a 1 gallon stainless steel Hamilton Beach blender, and
the herb-liquid mixture was transferred to a clean amber colored
gallon glass jar and sealed. Dried botanicals were ground in a 1
gallon stainless steel Hamilton Beach blender, transferred to a
clean amber colored gallon glass jar, and a mixture of distilled
water/190 proof ethanol/glycerol was added at a ratio of 1:5
(weight of botanical to volume of liquid). Distilled water/190 proof
ethanol/glycerol concentrations were as followed (Astragalus 74/
26/0; Andrographis 69/26/5; Sambucus 58/37/5; Urtica 55/37/8;
Echinacea 48/47/5; Tylophora 32/63/5). The mixtures were kept at
room temperature for 2 to 6 weeks, followed by separation of the
liquid portion from the solid herb portion using a mechanical
press. The extracted liquid was filtered using unbleached paper
filters, pooled, and dispensed in amber colored bottles. A sample of
each extract was dried and all extracts were found to contain
similar concentrations of non-volatile solutes (ranging between
62.4 – 136.8 mg/ml extract).
Endotoxin quantitation
Endotoxin levels in the botanical extracts were determined
using the Genscript ToxinSensor Chromogenic LAL Endotoxin
Assay Kit. The manufacturer’s protocol was followed and the
endotoxin units/ml (EU/ml) determined by comparison to an
Escherichia coli standard solution.
PBMC isolation: Human PBMCs were obtained from a
commercial source (Lonza, Inc., Allendale, NJ) or from freshly
drawn blood. Commercially obtained PBMCs were isolated from
peripheral blood by apheresis and density gradient centrifugation.
Cells were shipped on dry ice and stored in liquid nitrogen until
use.
For fresh PBMCs, blood was collected by venipuncture into
heparinized tubes. Whole blood was removed and added to an
equal volume of balanced salt solution (0.01% D-glucose,
0.005 mM CaCl2, 0.098 mM MgCl2, 0.54 mM KCl, 14.5 mM
Tris pH 7.6, 126 mM NaCl). Forty mls of blood/salt solution was
layered on top of 10 mls Ficoll-Paque Plus (Amersham Bioscienc-
es) and centrifuged at 4006g for 40 minutes at 20uC. PBMCs were
removed from the interface and washed in balanced salt solution.
The collection of fresh PBMCs was approved by the Arizona State
University and Southwest College of Naturopathic Medicine
(SCNM) Institutional Review Boards. Participants were recruited
from SCNM and blood draws performed at the SCNM Medical
Center. All participants received and completed a written
informed consent form prior to participation in the study.
Cell treatment
PBMCs were resuspended in RPMI1640 with 10% fetal bovine
serum (1610
6 cells/mL) in cell culture dishes. 1610
7 cells (in
10 mL media) were treated with 5 mL herbal extract or vehicle
(ethanol) for the indicated times (3–18 hours). Treatment of cells
with phorbol-12-myristate-13-acetate (PMA) (Calbiochem) was
done at a final concentration of 50 nM.
RNA isolation: Following treatment (3–18 hours), total RNA was
isolated and purified as per manufacturers protocol using an
RNeasy kit (Qiagen). Briefly, the cell lysate was homogenized
using a QIAshredder spin column. Any DNA contamination was
eliminated by DNase digestion and the RNA was isolated using
the RNeasy spin column.
Microarray analysis
One mg of high quality total RNA was converted into double-
stranded cDNA using the Affymetrix One-Cycle Target Labeling
Kit using an oligo-dT primer containing a T7 RNA polymerase
promoter. The double-stranded cDNA was cleaned using the
Affymetrix GeneChip Sample Cleanup Module and biotin-labeled
cRNA was made using the One-Cycle Kit. The biotin-labeled
Herbal Gene Regulation
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and quantitated on a spectrophotometer and analyzed on a 1%
agarose TAE gel to check for a wide distribution of cRNA
transcript sizes. Next, the cRNA was fragmented to approximately
35–200 bp by alkaline treatment (200 mM Tris-acetate, pH 8.2,
500 mM KOAc, 150 mM MgOAc) and fragmentation was
verified on a 1% agarose TAE gel. Separate hybridization
cocktails were made using 15 mg fragmented cRNA from each
sample.
A total of 200 mL of each hybridization cocktail was hybridized
to an Affymetrix Human Genome U133 Plus 2.0 array for
16 hours at 45uC in the Hybridization Oven 640. The Human
Genome array measures the expression of over 47,000 transcripts
and variants, including approximately 38,500 well-characterized
human genes. Arrays were washed on the Affymetrix GeneChip
Fluidics Station 450 according to manufacturer’s instructions using
a primary streptavidin phycoerythrin (SAPE) stain, subsequent
biotinylated antibody stain, and secondary SAPE stain. After
hybridization and washing, arrays were scanned using the
Affymetrix GeneChip Scanner 3000 7G. Scanned images
obtained by the Affymetrix GeneChip Operating Software
(GCOS) v1.2 were used to extract raw signal intensity values per
probe set on the array and calculate detection calls (absent,
marginal, or present). Assignment of detection calls was based on
probe-pair intensities for which one probe was a perfect match of
the reference sequence and the other was a mismatch probe for
which the thirteenth base (of the 25-oligonucleotide reference
sequence) was changed. All raw chip data was scaled in GCOS to
150 to normalize signal intensities for inter-array comparisons.
Reports generated in GCOS were evaluated for each array to
check for eukaryotic controls, maximum scaling factors of
approximately 3, at least 30% present calls (actual data ranged
from 37–48%), and maximum GAPDH (39/59) ratios of 3.0. All
microarray data is MIAME compliant and the full microarray
expression data has been deposited and is available in the MIAME
compliant database at: http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE19128.
Quantitative real-time PCR
The microarray results were confirmed by quantitative real-
time PCR (qPCR). Ten representative genes were selected from
the microarray expression profiles and changes in the expression
level confirmed using qPCR. qPCR was performed using iQSYBR
Green Super mix (Bio-Rad). Briefly, cDNA template for each
isolate was added to wells containing PCR reaction mix (iQSYBR
Green Super mix and primers). Primers were obtained from
SABiosciences. Reactions were done in a MiniOpticon real-time
PCR detection system with CFX Manager software control (Bio-
Rad).
Flow cytometry analysis
THP-1 cells were grown in RPMI1640 with 10% FBS in
nonadherent plastic dishes. Cells were treated with supernatant
from either mock treated PBMCs or PBMCs treated with PMA or
Astragalus extract for 18 hours. One million cells were washed
and resuspended in PBS containing 1% BSA, 0.1% sodium azide,
and 30% human AB serum (Innovative Research) followed by
staining for 30 minutes with antibodies specific for CD11b (clone
ICRF44), CD14 (clone MphiP9) or with isotype controls.
Antibodies were purchased as PE-Cy7 or APC-Cy7 conjugates
(BD, San Jose, CA). Propidium iodide was used to exclude dead
cells from analysis. Cell fluorescence was analyzed from samples of
20,000 cells using a BD Bioscience FACSAria with FACSDiVa
software.
Results
Peripheral blood mononuclear cells (PBMCs) are often
considered the industry standard for investigating many aspects
of immunological response in a cell culture system. As a mixed
population of T-lymphocytes, B-lymphocytes, natural killer cells,
monocytes, macrophages and dendritic cells, PBMCs represent
key cells involved in the genetic expression of cytokines leading to
innate and adaptive immune and inflammatory responses. To
investigate the cytokine response induced by immuno-stimulatory
herbal extracts, PBMCs were treated with an herbal extract
followed by microarray analysis on isolated cellular RNA. To date,
the effect of immuno-stimulatory herbs has only been evaluated by
observing the expression of a limited number of cytokines. Such
studies can be misleading and do not provide a broad or complete
understanding regarding the effect of the herbal extract on
immune cells. In our studies, 1610
7 cells were treated with 5
microL herbal extract for 18 hours. This concentration was based
on an average human prescribed dose in relation to the
approximate total blood volume (2.5 mL extract per 5 L blood).
Following incubation with the extract, total RNA was purified
from the cells and mRNA expression levels were evaluated by
microarray analysis using an Affymetrix platform.
These studies were done using herbal extracts historically used
to boost immune activity in patients, including Astragalus
membranaceus (Milk-Vetch Root, Huang qi), Sambucus cerulean (Blue
Elderberry), and Andrographis paniculata (India Echinacea, King of
Bitters). Since these extracts were prepared in an aqueous vehicle
containing ethanol and glycerol, PBMCs were treated with
identical concentrations of ethanol and glycerol in distilled water
(ethanol) as a control. Our initial method to measure modulation
in gene expression was done using scatter plot analysis. Treatment
of PBMCs with the vehicle solution had almost no effect on gene
expression when compared to untreated PBMCs (Figure 1A, Plot
A). However, as shown in Figure 1A, treatment of PBMCs with
Astragalus extract led to the alteration of expression of many
cellular genes (compare diffuse scattering of Figure 1A, Plot A to
Plot B). In this figure, the diagonal lines off the center represent 2-,
3-, 10-, and 30-fold levels of induction or repression of gene
expression. With Astragalus treatment, the expression of several
hundred cellular genes was altered, many to levels greater than 30-
fold relative to ethanol treatment alone (Figure 1A, Plot B). The
induction of gene expression was greater than the level of gene
repression in regard to the relative fold-change and number of genes
altered (146 genes induced with 58% induced greater than 10-fold
vs 118 genes repressed with 21% repressed greater than 10-fold). A
similar scatter plot appearance was observed after treatment with
Sambucus (Figure 1A, Plot C). After treatment of PBMCs with
Andrographis, similar fold changes of induction/repression were
observed, but fewer genes appeared to be affected (Figure 1A, Plot
D). Since all three of these immuno-stimulatory herbal extracts
produced relatively similar scatter plot profiles, an extract
prepared from the immuno-suppressive herb, Urtica dioica, was
studied. Treatment of cells with Urtica led to very limited or low
level changes in cellular gene expression (Figure 1A, Plot E). The
lack of change in gene expression after treatment with Urtica
argues that the alteration in gene expression by the immuno-
stimulating extracts (e.g., Astragalus) was not due to a non-specific
effect of any botanical extract, but instead was a legitimate effect
due to specific components present in the immuno-stimulating
herbal extracts. It was not surprising that the Urtica extract did not
alter gene expression since the PBMCs were from a reportedly
healthy individual and immune-suppressive effects would likely not
be observed. This effect has been observed previously where oral
Herbal Gene Regulation
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12561Figure 1. Scatter plot representation of botanical extract regulation of gene expression. Microarray analyzed gene data was plotted to
compare gene expression differences between botanical and ethanol treatment of PBMCs (Part A). Each spot on the plots represents a specific gene.
Only genes with present calls in both treatments are shown. The diagonal lines off the center represent 2-, 3-, 10-, and 30-fold levels of induction or
repression of gene expression. Part B illustrates comparative analysis between different botanical treatments of PBMCs.
doi:10.1371/journal.pone.0012561.g001
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expression in a healthy individual and only repressed cytokine
expression following lipopolysaccharide induction [32].
Although PBMCs represent the primary immune cells involved
in cytokine production, other cell types may also be involved in the
immune and inflammatory responses associated with these
botanical extracts. Therefore the intestinal cell line, Caco2 cells,
were used and changes in gene expression measured following
treatment with the botanical extracts. Results demonstrated no
dramatic changes in gene expression following treatment with any
of the botanical extracts (data not shown). Since PBMCs are key
cells involved in cytokine production, these results suggest that the
active constituents in these botanicals may interact with cells in the
PBMC population leading to changes in cytokine expression.
The microarray results from treated PBMCs were confirmed by
quantitative real-time PCR (qPCR). Ten representative genes
were selected from the microarray expression profiles and changes
in the expression level confirmed using qPCR. All ten genes tested
using qPCR showed comparable gene expression levels as those
obtained in the microarray analysis (Table 1). From our previous
experience with microarray studies, significant variations between
expression levels determined by microarray analysis or qPCR have
not been observed [33].
In order to compare the gene expression profiles altered by the
herbs, comparative scatter plots were done between the immu-
nostimulatory herbs. As shown in Figure 1B (Plot A), the genes
altered by Sambucus and Astragalus were very similar as indicated by
a lack of diffuse scattering of the genes. Treatment with Astragalus
did lead to additional changes in gene expression as compared to
Sambucus, indicated by a few genes induced 3–10 fold specifically
by Astragalus. These Astragalus specific alterations occurred toward
unique genes as well as to genes regulated by both Astragalus and
Sambucus but were induced to a higher expression level following
Astragalus treatment (Figure 2). More differences in gene expression
were observed when comparing Astragalus to Andrographis or
Sambucus to Andrographis (Figure 1B, Plot B and Plot C,
respectively). Again, the genes altered by these comparative herbs
were similar, but each herb also induced a unique subset of genes
(data not shown and Figure 2). This data suggests that immuno-
stimulating herbs may consistently affect a common set of genes
while also having additional unique effects on gene expression.
The cellular genes induced and repressed after treatment with
Astragalus were identified as (a) those genes which lie outside the
scatter plot profile of untreated vs. ethanol treatment (Figure 1A,
Plot A) and (b) those genes which were altered in gene expression
at least 3-fold compared to ethanol treatment alone. From our
experience and others on microarray studies, a fold-change of 2.5
or higher is typically considered significant; so limiting our fold-
change to 3-fold or higher provides strong confidence in the
validity that the expression of these genes was truly being altered
[33]. Following treatment of PBMCs with Astragalus extract,
approximately 150 genes were induced (data not shown). At least
65% of the genes that were induced by Astragalus are known to
have functions involved in the immune/inflammatory response.
Figure 2 (Astra column) shows the immune/inflammatory genes
induced upon treatment with Astragalus extract.
Previous studies on Astragalus have suggested that treatment
leads to (a) increased phagocytic activity of macrophages, (b) an
increase in proinflammatory cytokines IL1, IL6 and TNF, and (c)
an increase in levels of lymphocyte stimulatory IL2 and IL2
receptor expression [14,21,34,35]. Immune and inflammatory uses
of Astragalus include antimicrobial therapy [26,27,28], the
treatment of leukemia and lung cancer [35,36,37], and wound
healing [35,38]. Based on literature and anecdotal evidence,
Astragalus treatment may be associated with increased risk of
bleeding, and blood pressure lowering effects [39,40]. The genes
induced in our study by Astragalus treatment agree well with these
previous studies and the physiological effects of the herb on the
body. In PBMCs, IL1alpha, IL1beta, IL6 and TNFalpha
induced/interacting proteins (e.g., TNFAIP6) were highly in-
duced, as well as genes involved in immune cell stimulation,
chemotaxis, extravasation, and maturation/differentiation
(Figure 2). In addition, genes involved in increased risk of bleeding
(e.g., thrombomodulin, monoamine oxidase), regulation of blood
pressure (e.g., adrenomedullin, prostaglandin endoperoxide syn-
thase 2 [Cyclooxygenase-2], monoamine oxidase), and wound
healing (epiregulin, fibronectin type III, heparin-binding EGF-like
growth factor, interleukin 24) were identified (Figure 2). The effect
of Astragalus on the expression of most of these genes has not been
previously shown, and may provide new insight into the
physiological effects of this herb.
In support of the comparative scatter plots (Figure 1B), a very
similar set of genes regulated by the Astragalus extract was also
regulated by the Sambucus extract (Figure 2, compare Astra column
to Sambu column). This suggests that similar physiological
activities are present in both botanical extracts, however, the
active components may still be unique (i.e., conservation of
function with diverse chemical constituents). Treatment of cells
with the Andrographis extract also altered many genes in common
with Astragalus, but overall, the level of induction of genes regulated
by Andrographis was lower (Figure 2, Andro column).
Monocytes represent a significant percentage of cells present in
the PBMC population. They can mature into macrophages or
differentiate into dendritic cells (DCs) upon migration into tissues.
Monocytes that have matured into macrophages become more
adherent to tissue culture surfaces and increase expression of
CD11/CD18 integrins [41,42]. To test for monocyte maturation,
PBMCs were treated with Astragalus extract and assayed for the
effect on cell attachment. As shown in Figure 3A (upper panels),
treatment of PBMCs with Astragalus extract led to an increase in
adherent cells. Quantitatively, the number of adherent cells was
increased approximately 15-fold. These results suggest that
treatment of PBMCs with an immuno-stimulating herb, such as
Table 1. Quantitative real-time PCR (qPCR) verification of
microarray data.
Gene Microarray qPCR
IL8 +89.9 +111.4 (+6.8)
IL1beta +107.66 +137.2 (+7.1)
Oncostatin M +38.97 +18.4 (+4.2)
IL10 +8.02 +4.9 (+2.3)
Vanin 1 +117.33 +147.0 (+7.2)
CCL4 +8.39 +16.0 (+4.0)
Thrombomodulin +13.23 +14.9 (+3.9)
TLR5 24.54 24.0 (22.0)
CXCL9 225.0 213.0 (23.7)
IFNgamma 0 +1.4 (+0.5)
Select genes which were induced or repressed based on microarray data were
verified using qPCR. Microarray values are listed as the fold-change following
Astragalus membranaceus treatment relative to ethanol treatment. qPCR values
are listed as the fold change (outside parentheses) and the change in the cycle
threshold (Ct) (inside parentheses) following Astragalus treatment relative to
ethanol treatment (+ = induction, 2 = repression).
doi:10.1371/journal.pone.0012561.t001
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genes, but that these gene products are inducing immune cell
maturation and/or differentiation. It is known that IL4 and GM-
CSF mature monocytes towards DCs and that IL6 directs
monocyte maturation primarily towards macrophages [43]. Upon
treatment of PBMCs with Astragalus extract, IL6 expression was
highly up-regulated (Figure 2), whereas IL4 expression and GM-
CSF was unchanged. These results suggest that the monocyte
maturation observed upon treatment with Astragalus extract may
be directed toward a macrophage lineage. This is in agreement
with previous data in which the isolated APS polysaccharide from
Astragalus was shown to induce macrophage activation [44]. To
investigate if this monocyte maturation was due to a direct effect of
the extract on monocytes, monocyte to macrophage maturation
following treatment with Astragalus extract was tested using the
THP-1 monocyte cell line. Treatment of these cells with the
Astragalus extract led to no significant increase in adherent cells as
compared to untreated or ethanol treated cells suggesting the lack
of a direct effect of the extract on monocyte to macrophage
maturation (Figure 3A, lower panels). The maturation of
monocytes observed in the PBMC population may be linked to
cytokines released from other responder cells present in the PBMC
population (e.g., T helper cells). To test for this, the cell-free
culture media from untreated or Astragalus treated PBMCs
(24 hours post treatment) was added to THP-1 cells. As shown in
Figure 3B, an increase in adherent cells was observed in the THP-
1 cells treated with the cell-free media from Astragalus treated
PBMCs but not from untreated PBMCs. As a control, the cell-free
media from PMA-treated PBMCs was added to THP-1 cells.
Similar increases in adherent cells were observed using either cell-
free media from PMA or Astragalus treated cells (Figure 3B).
These results suggest that the Astragalus induced monocyte
maturation in the PBMC population was due to a secondary
effect following the release of cytokines from responder cells.
Maturation of THP-1 cells by cell-free media was further
monitored by the expression of CD14 antigen and by expression of
the b2 integrin component, CD11b, both of which are
upregulated when this promonocytic cell line differentiates into
mature monocyte/macrophage-like cells [45]. Incubation of THP-
1 cells with cell-free media from mock-treated PBMCs resulted in
15.4% of cells expressing CD11b while incubation with cell-free
media from either Astragalus- or PMA-treated PBMCs resulted in
28.5% or 28.6%, respectively, of cells expressing CD11b. It has
been previously shown that the presence of adhesion-associated
molecules on monocytes does not necessarily correlate with
adherence to a substrate, but that adherence requires intracellular
signaling which conformationally activates the adhesion molecule
[46]. Mock-treated THP-1 cells may therefore express an inactive
form of CD11b that does not mediate adherence (Figure 3C).
Incubation of THP-1 cells with cell-free media from mock- or
PMA-treated PBMCs resulted in 3.4% and ,1% of cells
expressing CD14, respectively. Incubation with cell-free media
from Astragalus-treated PBMCs resulted in expression of CD14 in
50.3% of the cells. In addition, extracts from Astragalus-treated
PBMCs caused a 4.5-fold increase in the percentage of double-
positive cells expressing both CD14 and CD11b as compared to
mock-treated PBMCs. Figure 3D shows averaged levels of
expression of total CD14 or CD11b positive cells and
CD14+CD11b+ double positive cells, normalized to mock levels,
from PBMCs isolated from two different patients. Although cell-
Figure 2. Host gene expression regulated by Astragalus membranaceus treatment of PBMCs. Genes were sorted based on a threefold
(P,0.01) or greater level of induction for Astragalus treated PBMCs for 18 hours (Astra column). Only genes involved in the immune/inflammatory
response are shown. Changes (n-fold) in expression level relative to those of ethanol-treated cells are shown within each box. Red boxes represent
genes induced 100-fold or higher, orange boxes represent genes induced 10 to 100-fold, and yellow boxes represent genes induced 3 to 10-fold.
Additional botanical treatments include Sambucus cerulea (Sambu column) and Andrographis paniculata (Andro column).
doi:10.1371/journal.pone.0012561.g002
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induced maturation as measured by cell adhesion and an increase
in percentages of total CD11b+ cells, only media from Astragalus-
treated PBMCs induced expression of CD14.
In general, the cytokine gene profile induced following
treatment with Astragalus was not strongly directed toward either
a Th1 or Th2 response, but rather a more generalized or
preparative immune/inflammatory response (see Figure 2). Most
genes involved in defining a Th1 or Th2 response remain
unchanged (eg. Th1: IFNgamma, IL18, SOCS1, STAT1, CSF2;
Th2: IL13, IL4, IL5, ICOS). However, gene expression profiles
have been defined regarding human monocyte to macrophage
maturation and polarization toward M1 or M2 phenotypes [47].
As shown in Figure 4, the gene expression profile of Astragalus
treated PBMCs follows an M1 polarization (with both induced and
repressed genes) with 83% of the genes defining the polarization of
M1/M2 macrophage matching that of an M1 lineage. In
agreement with this, COX-2 which was highly induced following
treatment with Astragalus (Figure 2), has long been associated and
induced in M1 macrophages [48]. Likewise, COX-1, which is up-
regulated in M2 macrophage [47], was slightly repressed following
Astragalus treatment (data not shown). These results suggest that
Astragalus treatment matured monocytes toward an M1 polariza-
tion.
Since the microarray data presented thus far represents
treatment of a single population of PBMCs from a commercial
source (Lonza, Inc. [identified as PBMC set I]), we wanted to
confirm that similar gene modulation would occur in fresh human
PBMCs. Fresh PBMCs were obtained and purified as described in
the Materials and Methods (identified as PBMC set II). Following
treatment of these cells with Astragalus extract, 123 genes were
found to be induced (Figure 5A, PBMC set II), giving a similar
response as that observed with the commercially obtained PBMCs,
PBMC set I (146 genes induced). Like PBMC set I, the genes
induced in PBMC set II primarily had an immune/inflammatory
role (65% vs. 62%, respectively). Although many of the
inflammatory genes induced were different between the two
PBMC populations, over 30% of the induced genes were identical.
This level of identity is high given that the PBMCs were from
different individuals and obtained from fresh vs. frozen. The genes
commonly induced are likely many of the key players involved in
the known physiological responses to Astragalus including those
Figure 3. Astragalus membranaceus treatment of PBMCs led to monocyte maturation. Part A) PBMCs (upper panels) or the monocyte cell
line THP-1 (lower panel) were untreated, treated with ethanol (25%), or treated with Astragalus extract for 18 hours. Following treatment, unattached
cells were removed and the remaining attached cells photographed. Part B) PBMCs were untreated or treated with Astragalus extract or PMA for
18 hours. After 18 hours, the cell culture media was removed and cells pelleted by centrifugation. The cell-free culture media was added to THP-1
cells for an additional 24 hours. Following treatment, unattached cells were removed and the remaining attached cells photographed. Part C) Cell-
free media from mock-, Astragalus, or PMA-treated PBMCs was added to THP-1 cells and incubated in uncoated plastic dishes. After 48 hours, cells
were washed and stained with fluorochrome-conjugated antibodies specific for CD14 and CD11b followed by flow cytometry analysis. Part D) Cell-
free media obtained from PBMCs isolated from two patients were used to treat THP-1 cells and analyzed for CD14 and CD11b expression as in Part C.
Values indicated represent total CD14 cells, total CD11b cells and CD14/CD11b double-positive cells. Data was normalized to mock-treated samples.
doi:10.1371/journal.pone.0012561.g003
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(eg. CCL3, CCL4, CXCL1, CXCL2, CXCL3, IL1alpha, IL1beta,
IL6 and IL8), as well as wound healing and blood coagulation (eg.
coagulation factor III, prostaglandin endoperoxide synthase 2,
thrombomodulin, and IL24) (see Figure 5B, panel A).
Genes that were induced in only one of the PBMC sets are likely
related to human to human genetic variations and/or physiolog-
ical state of the individual at the time of the blood draw. Many of
the uniquely induced genes represented functional families of
genes. For example, in PBMC set I following treatment with
Astragalus, several metallothioneins, vanins, and integrins were
induced (Figure 5B, panel B). In PBMC set II, these gene families
remained primarily unchanged, however gene families including
colony stimulating factors, dual specific phosphatases, and growth
arrest and DNA-damage inducible were induced. Notably, PBMC
set II also led to the unique induction of CD69, early growth
response 1 and microRNA 155 which are all key proteins involved
in the inflammatory response (Figure 5B, Panel B). Previous
studies demonstrate that considerable natural variation in gene
expression levels exists within and among human populations [49].
When they compared individuals, gene expression variations
occurred in an estimated 83% of genes. Genes which are
differentially expressed among populations may be particularly
relevant as candidates for disease, or in our studies, for differences
in the immune response.
We also identified over 100 cellular genes which were repressed
in expression levels after treatment with Astragalus (Figure 5A). In
this data set, the majority of the genes (approximately 70%) were
not directly involved in the inflammatory/immune response, but
were genes involved in metabolic pathways such as lipid and
carbohydrate metabolism (e.g. fructose-1,6-biphosphatase 1,
fucosidase, lipase A, and alpha galactosyltransferase 1). This data
supports the concept that these herbs are involved in the induction
of a systemic inflammatory and immune response. Again, when
PBMC set I and PBMC set II were compared, similar numbers
and percentages of genes were repressed (Figure 5A), but for those
genes involved in the inflammatory response, specific gene families
to each PBMC set were repressed. For PBMC set I, several major
Figure 4. Transcriptional profiling of M1/M2 macrophage polarization induced by Astragalus membranaceus. Human genes involved in
defining M1/M2 polarization are shown [47]. The transcriptional regulatory effect of each gene following treatment of PBMCs with Astragalus extract
is indicated (‘Expression’ column), with positive values representing increased expression, and negative values representing repressed expression. The
‘X’ (in the ‘M1 like’ or M2 like’ column) indicates that the change in gene expression (induced or repressed) following Astragalus treatment was similar
to that previously observed following monocyte maturation to either an M1-like or M2-like macrophage polarization.
doi:10.1371/journal.pone.0012561.g004
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(Figure 5B, panel C). For PBMC set II, repressed gene families
included leukocyte immunoglobulin receptors, C-lectin domain
family members, neutrophil cytosolic factors and metallothioneins
(Figure 5B, panel C). At this time, it is difficult to speculate on
what role the suppression of these inflammatory gene families may
play in the physiological effects of Astragalus.
In order to further understand the temporal effect of Astragalus
treatment on immune cells, PBMCs were treated with the
botanical extract and microarray analysis performed on RNA
samples prepared at 3, 8 and 18 hours post treatment. Figure 6A
shows scatter plot representation of gene expression levels of
ethanol treated PBMCs in comparison to cells treated with the
Astragalus extract for the indicated times. As shown, the cellular
transcriptional response to the herbal extract was rapid with a
dramatic induction/repression of several hundred genes by
3 hours post treatment (Figure 6A, panel A). By 8 and 18 hours
post treatment, fewer genes were induced/repressed, but still
represented 100–200 genes (Figure 6A, panels B and C). The
induction of genes by Astragalus was biphasic with different families
of genes being induced at different times post treatment. As shown
in Figures 6B and 6C, at 3 hours post treatment, there was a
predominance of genes (approximately 40%) involved in tran-
scriptional, translational and signal transduction processes with
only 26.6% of genes having an inflammatory role. However, by 8
and 18 hours post treatment, approximately 70% of the genes
induced were involved in the immune/inflammatory response
(Figure 6B and 6C). The immune genes which were induced at
3 hours post treatment typically continued to be induced through
18 hours, including various chemokines (CCL3, CCL4, CCL20)
and interleukins (IL1beta and IL6) (Figure 6C). Interestingly, there
are differences in the immune/inflammatory genes induced
between 8 and 18 hours post treatment. Genes involved in the
type I interferon response, such as interferon-induced 44 and
Figure 5. Different PBMC isolates led to similar changes in gene expression following treatment with Astragalus membranaceus.
Commercially available (PBMC set I) or fresh PBMCs (PBMC set II) were treated with Astragalus extract for 18 hours. Genes were sorted based on a
threefold (P,0.01) or greater level of induction or repression relative to ethanol-treatment. Part A represents the overall comparison of genes
regulated between PBMC set I and PBMC set II. For Part B, specific immune/inflammatory genes commonly or uniquely altered in expression
following Astragalus treatment of PBMC set I and PBMC set II are shown. Changes (n-fold) in expression level relative to those of ethanol-treated cells
are shown within each box. Red boxes represent genes induced 100-fold or higher, orange boxes represent genes induced 10-100-fold, and yellow
boxes represent genes induced 3-10-fold.
doi:10.1371/journal.pone.0012561.g005
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the 8 hour time point (Figure 6C). Likewise, several interleukins
were only induced at the 18 hour time point, including IL12B and
IL24 (Figure 6C). Since PBMCs contain a variety of immune cells,
these temporal effects may be due to constituents present in the
herbal extract interacting with (a) responder cells which subse-
quently induce/release cytokines and lead to transcriptional
responses in other effector cells, or (b) cells which induce cellular
receptors/signal transduction processes which, after expression, can
respond to additional herbal constituents leading to inflammatory
gene induction.
Lipopolysaccharides (LPS) are major components of the outer
membrane of Gram-negative bacteria and highly potent activators
of the innate immune response. The interaction of LPS via CD14
with cells, such as macrophages, granulocytes, and dendritic cells,
leads to the synthesis of a multitude of inflammatory mediators
[50,51]. However, strong inflammatory responses to LPS can be
hazardous and may lead to endotoxin shock and death [50,51].
Therefore the presence of LPS or endotoxin contamination in
pharmaceutical drugs and medicines is a common concern. The
herbal extracts used in these studies were assayed for the presence
of endotoxin using a modified Limulus Amebocyte Lysate kit. As
shown in Figure 7, herbal extracts historically reported and used to
stimulate the immune response (Astragalus membranaceus, Sambucus
cerulea, Andrographis paniculata, Echinacea angustifolia and Glycyrrhiza
glabra) [10,52,53,54,55]) had highly elevated levels of endotoxin
(.100 EU/ml). Those herbal extracts historically used to repress
immune activity (Urtica dioica and Tylophora asmatica) [56,57]) had
much lower endotoxin levels (,100 EU/ml). This correlation
between activity and endotoxin concentration may suggest that the
presence of LPS was not due to contamination of the extract, but
instead was a common constituent of the immune-stimulatory
extracts and as such, may play a role in immune regulatory
activity. In order to confirm that the LPS present in the extracts
was not due to contamination during harvesting or extract
preparation, multiple extracts of Astragalus and Urtica were
prepared using different lots of plant material from the suppliers.
As shown in Figure 7, all the extracts of Astragalus had high
endotoxin levels (.100 EU/ml) and all the extracts of Urtica had
low endotoxin levels (,100 EU/ml). This further supports that the
presence of LPS in the botanical extracts was not due to exogenous
bacterial contamination during harvesting, handling, or extract
preparation, and instead was likely due to the lysis of endophytic
bacteria which colonize the internal tissue of the plants in a
mutualistic and asymptomatic fashion. Of the nearly 300,000
plant species that exist on earth, it is believed that each individual
plant is host to one or more bacterial endophytes [58,59,60].
Endophytes are defined as endosymbionts that live within a plant
without causing any apparent disease. Endophytes are not only
found in the roots and in the rhizosphere, but are often found to
Figure 6. Temporal regulation of gene expression in PBMCs following Astragalus membranaceus treatment. PBMCs were treated with
Astragalus extract for 3, 8 or 18 hours. Microarray analyzed gene data was plotted to compare gene expression differences between botanical and
ethanol treatment of PBMCs (Part A). Each spot on the plots represents a specific gene. Only genes with present calls in both treatments are shown.
The diagonal lines off the center represent 2-, 3-, 10-, and 30-fold levels of induction or repression of gene expression. Part B represents the roles and
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plant compartments, including seeds [60]. A vast number of these
endophytes, including Rhizobium sp. which has been isolated from
Astragalus, are Gram-negative bacteria [59]. Based on this, it is
expected that many botanical extracts would contain LPS due to
lysis of these bacterial endophytes.
Discussion
The goal of this study was to obtain a more complete
understanding of the regulation of cellular gene expression by
various immuno-stimulatory herbs. Since the personal use and
prescribing of total herbal extracts has increased dramatically in
recent years, this study sought to measure changes in cytokine
gene expression in cells treated with a total botanical extract. Even
though these assays were done in a cell culture system, the results
may aide in understanding the physiological effects thought to be
associated with administration of these extracts to individuals.
Administration of these herbal extracts to individuals is typically
done orally, leading to sublingual and intestinal uptake of the
active constituents into the bloodstream. It is unknown if these
constituents are altered in the enteric environment, however
sublingual administration allows direct diffusion into the blood-
stream. Once in the bloodstream, these constituents likely interact
with PBMCs leading to cytokine production. Although many
studies focus on identifying the key active constituents present in
an herbal extract, this was beyond the scope and focus of this
study. Validation and confidence in the data obtained from the
microarray expression studies was supported in our results where
(1) many of the genes altered in expression were detected by
multiple probe sets present on the microarray chips and
demonstrated similar levels of expression between these probes
(Figure 3), (2) many genes altered in expression were similarly
altered by different herbs used in this study (Figure 3), (3) different
cellular samples had a significantly similar set of genes altered in
expression (Figure 5), (4) quantitative real-time PCR of select genes
demonstrated similar changes in gene expression as obtained in
the microarray study (Table 1), and (5) only those genes with a 3-
fold or greater (P,0.01) change in expression were included in our
analysis.
Astragalus is a staple of Traditional Chinese Medicine being one
of the oldest medicinal herbs listed in the material medica of
Chinese herbal medicine [61]. Chinese herbalists have used
Astragalus to supposedly help the human body resist disease [62]. It
is the most commonly used herb in Chinese medicine. Modern
herbalists utilize Astragalus primarily as an immunostimulant to
prevent common infection and aid in the recovery following
infection [62]. Several animal studies and double-blinded,
randomized human pilot studies have demonstrated an effect on
cytokine production and immune cell activation following
ingestion of Astragalus extracts [8,9,10,11,12,13,14,15,16,17,
18,19,20,21]. Historically, the biological activities associated with
Astragalus have been accounted for, at least in part, to several
constituents present in the herb including flavonoids, saponins,
and polysaccharides [61,63]. Our data suggests that LPS present
in the Astragalus extract may be a key component as well. Astragalus
led to the induction of IL1alpha, IL1beta, IL6, and IL8 which
likely leads to an early proinflammatory response. These
Figure 7. Endotoxin concentration present in botanical extracts. Endotoxin concentrations in the botanical extracts listed were measured
using a modified Limulus Amebocyte Lysate assay. Concentrations (endotoxin units/ml; EU/ml) were determined by comparison to an Escherichia coli
standard solution. For Astragalus and Urtica, multiple extract preparations were prepared at different times using multiple lots of plant material
obtained from the supplier (Samples I–IV and Samples I–V, respectively).
doi:10.1371/journal.pone.0012561.g007
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were upregulated by all three immune stimulatory herbal extracts
tested [64]. The Th1-specific cytokines, IL2, TNFalpha, and
IFNgamma, were not upregulated in either of the samples and
may suggest that an infectious agent may need to be present to
further drive the immune response. Surprisingly, TNFalpha,
which is known to be induced by LPS, was not detected after
Astragalus treatment [64]. This may suggest that the type(s) of LPS
present in the extract does not induce TNFalpha or that other
components of the extract act to inhibit the induction of
TNFalpha. An alternate explanation may be that the LPS-
inducible regulatory cytokine IL10 which was detected in both
PBMC samples acted to down regulate or prevent induction of
IL2, TNFalpha and IFNgamma which may be important in
protection from necrotic injury. However induction of the alpha
chain of the IL-2 receptor was observed in both samples suggesting
a readiness to induce a Th1 response in the advent of infection.
Additionally, Astragalus has been described as being able to redirect
an underlying Th2 immune response toward a Th1 response as
seen in patients with chronic viral infection or cancer [8,37]. Our
microarray data supports this idea since we observed the
modulation of multiple genes fitting an M1-type macrophage
profile to be up-regulated in our PBMCs [47]. The ability of
Astragalus to shift the immune response toward a Th1 phenotype is
supported by previous in vivo studies of viral infection which
require a Th1 response for resolution [8,27,29,30].
Based on the characterized functions and activities with
Astragalus, our microarray data is in agreement with the historical
uses of Astragalus and may provide additional insights into how this
herb may be inducing putative physiological effects. As well as
those cytokines previously described as being up-regulated by
Astragalus, we found additional cytokines induced by this herb,
many of which play a role in chemotaxis and extravasation (e.g.
CCL2, CCL7, CCL19, CCL20, CXCL1, CXCL5, CXCL6,
CXCL13, formyl peptide receptor 1 and 2, MMP1, MMP12 and
mucin-like 1). A number of these cytokines can be induced by LPS
in macrophages from healthy patients (CCL19, CCL20, CXCL1,
CXCL13, MMP1) and is associated with genes responsive to NF-
kB [65]. However, many LPS-responsive genes with or without
NF-kB binding sites were not induced by Astragalus and suggests
alternate modes of gene regulation by the extract. Based on our
data, Astragalus appears to induce a generalized and/or preparative
state regarding stimulation of the immune response, which agrees
with the suggested physiological effects of this herb. Of note,
multiple MIPs (macrophage inflammatory proteins) were induced,
including MIP-1a, MIP-1b, MIP-2a, and MIP-2b (also termed
CCL3, CCL4, CXCL2, CXCL3, respectively). CCL3, CCL4, and
CXCL2 are known to be induced by LPS and may suggest a role
for this Astragalus component in the mobilization of polymorpho-
nuclear leukocytes for innate defense [65].
In addition to these effects on the immune response, Astragalus
has been described as having an effect on wound healing and
blood pressure modulation. In regards to the role of Astragalus with
wound healing, no cellular proteins had previously been described
as being involved in this physiological response. It has recently
been shown that Astragalus extracts significantly accelerated
cutaneous wound healing by stimulating basal cell growth in the
wound area and promoting angiogenesis [38]. From our
microarray studies, several putative proteins were identified which
could affect wound healing. These include adrenomedullin,
fibronectin type III and SPRY domain containing 1-like, heparin
binding EGF-like growth factor, vascular endothelial growth factor
(VEGF), hyaluronan synthase 1, sphingosine-1-phosphate phos-
phatase 2, and IL24. In addition, several genes which were
induced (epiregulin, matrix metallopeptidase 14, podoplanin,
VEGF, thrombospondin-1) are key players in angiogenesis. This
agrees with recent reports which suggest that Astragalus promotes
angiogenesis and induces VEGF expression [38,66]. Most of the
above genes are not known to be responsive to LPS with the
exception of VEGF and possibly sphingosine 1-phosphate
phosphatase 2 which both contain NF-kB binding sites in their
promoters [67,68]. Additionally, LPS is known to adversely impair
wound healing [69]. This suggests that alternate components of
Astragalus are likely mediating the wound healing and angiogenic
effects and may be modulating the activities of LPS. Regarding
blood pressure modulation, prostaglandin-endoperoxide synthase
2 (COX-2), adrenomedulin (ADM) and monoamine oxidase were
all induced and are known to be involved in vasodilation. LPS
induces both COX-2 and ADM and may be an active component
associated with blood pressure modulation [65,70]. The vasode-
pressor role of the COX-2 gene product has been shown to be
regulated and dependent on the activity and ratio of both COX-1
and COX-2 [71]. Notably, treatment of PBMCs with the Astragalus
extract led to a high induction of COX-2 transcription while
slightly inhibiting COX-1 gene expression possibly supporting a
vasodepressor effect. Similarly, several proteins were induced
which can affect blood coagulation, including coagulation factor
III, integrin b3, and thrombomodulin, and these genes have not
been shown to be LPS-induced. Interestingly, thrombomodulin
can prevent LPS induction of inflammatory molecules by the
inhibition of NF-kB signaling [72]. Botanical components, as well
as the natural presence of LPS in the Astragalus extracts may
together be responsible for the induction of genes involved in
angiogenesis, modulation of blood pressure, and blood clotting
[73,74,75]. Further studies are required to determine the effects of
other components present in the Astragalus extracts that may
modulate the activities of LPS in putative physiological roles.
Sambucus extract, like Astragalus, is primarily prescribed for its
immune-modulating, antioxidant and antiviral activities. Limited
studies with Sambucus have demonstrated its ability to significantly
increase the production of IL1beta, IL6, IL8, and IL10 [24,53].
These cytokines were similarly upregulated in our microarray
studies, as well as many other cytokines. For the antioxidant
activity associated with Sambucus, we found that superoxide
dismutase 2 was highly induced and could be associated with this
activity. Both Sambucus and Astragalus induced a very similar set of
cytokines, and typically, with a very similar level of induction.
Though not well characterized, the immunologically active
constituents of Sambucus likely include flavonoids and anthocyanins
[76], as well as LPS as determined in this study. This data suggests
that these divergent herbs have similar effects on immune cells,
though possibly through distinctly different effectors.
Andrographis extract has traditionally been used for its anticancer
and immunomodulatory activity [55,77]. In our microarray
results, Andrographis induced many immunostimulatory genes
similar to Astragalus and Sambucus, but was substantially different,
typically with the expression of many fewer genes being altered.
This may suggest that Andrographis does have immunostimulatory
activity, but the effect on the immune cells may be greatly reduced
or directed toward a more specific response. Unfortunately, a
direct comparative study between these herbs has never been
done. Interestingly, Andrographis has been suggested to decrease
blood pressure [78] as does bacterial LPS [79], and like Astragalus,
it led to the induction of vasodilators, including adrenomedullin
and prostaglandin-endoperoxide synthase 2 (COX-2).
Urtica is typically used for rheumatologic conditions due to its
anti-inflammatory and immunosuppressive activities [57]. In our
study, this herb was effective in demonstrating that the genes
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due to the exposure of any botanical extract to the immune cells.
Treatment of cells with the Urtica extract led to almost no changes
in cellular gene expression. This supports a previous clinical study
where administration of Urtica to a healthy individual had no effect
on cytokine gene expression, including TNF, IL1, IL4, IL6 and
IL10 [32]. However, following immunostimulation in these
subjects, Urtica was able to reduce the expression of these
cytokines, and this activity is likely due to the ability of Urtica to
inhibit activation of the transcription factor, NF-kB [80].
The level of expression is an important aspect of gene action. It
is clear that reduced or increased gene expression can influence
many quantitative traits., Immunostimulatory herbs may alter the
expression of similar genes, but may also have dramatically
different effects on the physiological response through significant
differences in gene expression levels or specific differences in genes
regulated. Many botanical extracts, including those in this study,
have been used for their antimicrobial activity [31]. Although
some of this activity may be due to a direct antimicrobial effect
from these herbs, much of this activity may be due to the
immunostimulatory activity which we have described.
Astragalus treatment led to the induction of specific proinflam-
matory cytokines over the entire course of treatment (from 3 to
18 hours). However, there was also a distinct temporal response in
gene expression. Early after treatment, many of the genes induced
were involved in signal transduction processes and RNA/protein
modification. Following this initial response, the subsequently
induced genes were primarily involved in amplifying the
inflammatory response. This type of temporal inflammatory
response has previously been observed in mice treated with
immunostimulants. Han, et al. found that immuno-stimuli led to
the early induction of several genes, including cytokines, which
subsequently led to the secondary induction of gene expression.
Though not completely understood, this type of temporal
activation is thought to be associated with amplified, perpetuated
and sustained inflammatory processes [81]. This type of response
would fit with the physiological activity for which Astragalus is
utilized.
It has been previously described that considerable natural
variation in gene expression levels exists within and among human
populations [49]. In our study, using PBMCs from two distinctly
different individuals, over 30% of the genes induced by Astragalus
were commonly altered in expression. Based on genetic diversity,
this level of similarity was notable and likely represents those genes
characteristically induced by Astragalus in immune cells. As
expected, many of these conserved genes are involved in the
proinflammatory response as well as wound healing, decreasing
blood pressure and increasing the risk of bleeding, (including
various cytokines and interleukins, hyaluronan synthase 1,
sphingosine 1 phosphatase 2, thrombomodulin, epiregulin,
monoamine oxidase, prostaglandin-endoperoxide synthase 2
[COX-2]). As expected with human diversity, each individual
sample also induced a specific subset of genes. The vast majority of
these genes were involved in the immune/inflammatory response
and likely represent individual responsiveness to the botanical
immune stimuli. For example, PBMCs from one individual
induced high levels of the gene family of colony stimulating
factors (CSF1, CSF2 and CSF3) following treatment with
Astragalus. These genes were unaltered in expression in the other
PBMC set. Given that these CSFs aid in stimulating the
production of various white blood cells, they are key factors in
the proinflammatory response. Since these genes were expressed
with individuality, they likely affect the individual responsiveness
and effectiveness to Astragalus in regards to the immune response.
As mentioned, all the extracts used in this study are
representatively the same as those regularly prescribed to patients
by licensed physicians in the complementary and alternative
medicine field. With four different immuno-stimulatory herbs
tested (Astragalus, Sambucus, Andrographis, and Echinacea), all were
found to have relatively high levels of LPS present in the extract.
Importantly, much lower levels of LPS were detected in extracts
from herbs historically used for immuno-suppression (Urtica, and
Tylophora). Our data supports that this LPS was not due to
contamination during harvesting, handling or extract preparation,
but instead was due to symbiotic endophytic bacteria present in
the plants. Since a vast number of botanical endophytic bacteria
are Gram-negative [59], the LPS present in the extracts was likely
obtained by lysis of these bacterial cells. Although identifying the
active constituents present in these botanical extracts was not the
focus of this study, our data supports a role of LPS in regulating
the immunological response. Future studies will focus on
deciphering the specific types and role of LPS in these cellular
responses.
All extracts utilized in this study were prepared by Herbal
Vitality, Inc. (Sedona, Arizona, USA). This company was chosen
since they are a source for herbal products used by licensed
practitioners in the field. This company ensures identification of all
plant species and prepares highly active and reproducible herbal
extracts according to traditional and accepted extraction methods
used in the complementary and alternative medicine field. This is
an important aspect of this study since all the extracts used in this
study are representatively the same as those regularly prescribed to
patients by licensed physicians. Previous studies on immune-
stimulating herbs have commonly focused on purifying active
components which are free of endotoxins. For this study we
wanted to evaluate the cellular response to immune-stimulatory
herbal extracts in the context of extracts representative of those
which are prescribed to patients. Since many of these prescribed
immunostimulatory extracts appear to contain LPS, likely from
the lysis of endophytic bacteria, this research represents a more
physiologically relevant study to investigate the potential cellular
response following exposure to the whole herbal extract.
As mentioned above, various components from these immuno-
stimulatory herbs have been shown to have immuno-stimulatory
roles and act to induce cytokine expression. Based on the known
roles of LPS, it is expected that the LPS present in these extracts is
influencing immune gene expression as well. The cytokines,
IL1alpha, IL1beta, IL6, and IL10 were expected to be induced by
LPS, however we did not observe induction of other typically-
induced cytokines like TNFalpha or MCP-2. However, LPS
structure and activity varies greatly between different bacteria and
LPS structures on endophytic bacteria have not been well
characterized [50]. Indeed, Rhizobium sp. has been shown to
establish a symbiotic relationship with the roots of Astragalus
[82,83]. Unlike LPS derived from enterobacteria, which activates
immune cells via the transmembrane Toll-like receptor 4 (TLR4),
the structurally different LPS from Rhizobium acts through TLR2
and TLR6 [50,51,82]. Although TLR2 and TLR6 are thought to
be similarly involved in immune cell stimulation, the gene
expression profiles and cellular response may be different than
activation through TLR4. Endophytic bacteria have been
identified in the tissues of every living plant known [58,59,60].
Since botanical extracts have been used by humans for centuries
for the treatment of various medical conditions, components from
these bacteria may be involved in the historical activities associated
with these herbs. Recent studies support that botanical endophytic
microbes synthesize active antiviral, anticancer, antioxidant and
immunosuppressive compounds [58]. LPS from these bacteria
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the activity of these herbs. Future studies will focus on the isolation
and characterization of the LPS from the endophytic bacteria and
on determining the specific role in regulating gene expression and
the inflammatory response.
In conclusion, though microarray analysis does not provide
conclusive proof that the genes induced by the immunostimulatory
herbs are responsible for the physiological effects observed in
humans following administration of the various herbs, it does
provide insight into putative genes and directions for future
research. It should be noted that many herbs, including Astragalus,
are typically considered safe, even at high doses and prolonged use
[84]. Our data supports that Astragalus treatment induced genes
involved in a strong, generalized proinflammatory response. This
immune response may be responsible for much of the antimicro-
bial activity associated with Astragalus. However, care and further
investigation should be considered regarding prolonged, uninter-
rupted use of some herbs, such as Astragalus, which may lead to
physiological effects associated with sustained inflammatory
activity.
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